Sabra Health Care REIT, Inc.
No SEC Form 4 filings for $SBRA in the last 30 days.
See all $SBRA insider activity →Senior housing REITs are poised to benefit from the aging U.S. population. Ventas (VTR) and Welltower (WELL) report growth in senior housing occupancy and revenue. CareTrust (CTRE), Sabra (SBRA), and LTC (LTC) offer higher yields due to skilled nursing exposure. Key financial data and risks are outlined for each REIT.
Wells Fargo maintained an Overweight rating for Sabra Health Care REIT (SBRA) but lowered its price target to $21.00 from $23.00. The company's GF Value™ is $20.74, suggesting a 7.7% undervaluation. SBRA has a GF Score™ of 84/100, indicating strong performance. Insider activity shows significant selling, with $4.166 million in sales over the last three months.
MATROS RICHARD K (Chair, CEO and President) sold 200,000 indirectly-held shares of Sabra Health Care REIT, Inc. (SBRA) at $20.83 ($4.17M total) on 2026-09-08 under a Rule 10b5-1 trading plan.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning SBRA (Sabra Health Care REIT, Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent SBRA coverage spans sector analysis, financial news and earnings.
Elevated yield may sustain interest, yet no novel information.
Analyst price‑target cut signals weaker outlook and may prompt sellers.
Insider sale of $4.2M may signal reduced confidence from top management.
Downgrade-to-neutral style improvement can reduce downside pressure, though lack of target limits conviction.
Cash-flow coverage looks intact, but the large loan-loss provision and ongoing Avamere transition risk keep credit volatility in focus.
AlphAI scores every news story that mentions SBRA with an AI model for sentiment and relevance, and aggregates insider trades from Sabra Health Care REIT, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Senior housing REITs are poised to benefit from the aging U.S. population. Ventas (VTR) and Welltower (WELL) report growth in senior housing occupancy and revenue. CareTrust (CTRE), Sabra (SBRA), and LTC (LTC) offer higher yields due to skilled nursing exposure. Key financial data and risks are outlined for each REIT.
3 min readWells Fargo maintained an Overweight rating for Sabra Health Care REIT (SBRA) but lowered its price target to $21.00 from $23.00. The company's GF Value™ is $20.74, suggesting a 7.7% undervaluation. SBRA has a GF Score™ of 84/100, indicating strong performance. Insider activity shows significant selling, with $4.166 million in sales over the last three months.
1 min readMATROS RICHARD K (Chair, CEO and President) sold 200,000 indirectly-held shares of Sabra Health Care REIT, Inc. (SBRA) at $20.83 ($4.17M total) on 2026-09-08 under a Rule 10b5-1 trading plan.
1 min read24/7 Wall St. lists Thursday analyst calls. JPMorgan upgraded Charles River Laboratories (CRL) to Overweight, target $310. Wolfe raised Global Payments (GPN) to Outperform, target $110. Argus upgraded Roper Technologies (ROP) to Buy, target $450. Piper cut AppLovin (APP) to Neutral, target $385, and HubSpot (HUBS) to Neutral, target $220. Several other upgrades, downgrades, and initiations are noted.
4 min readSabra Health Care REIT (SBRA) shares rose about 0.2% to around $20.66 after Q2 2026 results. Revenue increased to $238.09 million from $189.98 million, but net income fell to a $25.20 million loss from a $65.54 million profit. Normalized FFO was $0.38 and adjusted FFO $0.40, supporting a $0.30 dividend. The company recorded a $102.4 million loan loss provision.
5 min readSabra Health Care REIT, Inc. (SBRA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE SABRA REPORTS SECOND QUARTER 2026 RESULTS; REITERATES 2026 GUIDANCE TUSTIN, CA, August 3, 2026 — Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the second quarter of 202
6 min readThe article highlights four high-yield stocks and one mortgage REIT, focusing on dividend yield, volatility (beta), and recent actions. First Interstate BancSystem (FIBK) announced a $150M buyback, totaling $450M, after repurchasing about 8%. Sabra (SBRA) raised full-year FFO/AFFO guidance after a tenant transition with ~30% higher rent. Getty Realty (GTY) and Kinetik (KNTK) are discussed, and Ellington Financial (EFC) is noted for an 11.5% yield with adjusted distributable earnings guidance of
7 min readSabra Health Care REIT (SBRA) shares rose over 10% after the company issued an operational update. Sabra said it signed letters of intent to retenant 26 Avamere properties, targeting $53M annual rent versus $41M prior. It also arranged to retire a $300M RCA mortgage with $200M cash. Sabra raised 2026 guidance to $0.37-$0.39 headline net income and $1.59-$1.61 normalized AFFO.
5 min readAvamere plans to exit skilled nursing by ending management agreements for 26 Sabra Healthcare REIT (SBRA) properties. Sabra will reassign 22 sites to Cascadia Healthcare and four to subsidiaries of an existing tenant. Sabra set Cascadia’s closing rent at $53 million, with the deal expected to close this year, according to Sabra.
5 min readFitch Ratings said four senior housing REITs, CareTrust (CTRE), National Health Investors (NHI), Sabra (SBRA) and Omega (OHI), earned similar “BBB-” credit ratings. Fitch cited differences in liquidity and leverage, noting a trend to reduce skilled nursing exposure and expand managed operating platforms, including RIDEA structures. It also highlighted U.K. exposure and NHI’s positive outlook factor.
7 min read
